Nitrofurantoin Capsules recall — Class II (D-0168-2025) · pharmaranks
Class IIOngoing
Nitrofurantoin Capsules recall
FDA recall D-0168-2025 · initiated Dec 4, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Failed Dissolution Specifications
Details
Product
Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15.
Recalling company
AvKARE
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide USA
Initiated
Dec 4, 2024
FDA report date
Jan 8, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.